The Maurice Wilkins Centre Board monitors the progress of the Centre's research programme as well as its outreach and education outcomes, and also monitors compliance with its funding mandate and budget.
The Board also provides advice and direction to the Management Committee (which comprises the Centre’s ten current management principal investigators) on strategies for development of the Centre’s research programme, and on matters of administration, external relations and international engagement.
Maurice Wilkins Centre Board
CHAIR Mr William (Bill) FalconerCNZM, LLB
Mr Falconer has had a noteworthy career in government, concluding as Deputy Secretary of Energy from 1980-1985, and in business as a professional company director for more than 25 years. He was made a Distinguished Fellow of the Institute of Directors in 2006 and has chaired many organisations including Maui Development Ltd, the Natural Gas Corporation, Southern Petroleum, St Lukes Group, the Accident Compensation Corporation, The Environmental Risk Management Authority, Hellaby Holdings and Restaurant Brands, Primary Growth Partnership Investment Advisory Panel, Rowing New Zealand and the Meat Industry Association. He was named a Fellow of the University of Auckland in 2011, for his outstanding contribution to the University as Founding Chair of the Board of the Maurice Wilkins Centre.
Ms Maxine SimmonsMSc
Ms Simmons is Managing Director of Biocatalyst Ltd. She co-founded ICPbio a New Zealand company that became a world leader in biological pharmaceuticals for animal reproduction, and has since established biotechnology advisory business Biocatalyst Ltd. She began her career in medical research at The University of Auckland and Auckland Blood Transfusion Service and has been a director on the Foundation for Research, Science and Technology Board, Chair of Technology New Zealand, and a founding member of the Industry New Zealand Board (now New Zealand Trade and Enterprise), and Chair of NZBIO. She is a member of the New Zealand Institute of Directors and is a director of several privately held New Zealand companies in the healthcare sector.